Haemonetics | HAE - Loan Capital


Haemonetics reported $1.17B in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Baxter International USD 8.62B 6M Jun/2026
Becton, Dickinson and Co. USD 13.51B 1.2B Jun/2026
Boston Scientific USD 10.86B 148M Mar/2026
Cerus USD 64.86M 22K Dec/2024
Cooper Companies USD 1.86B 17.7M Mar/2026
Fresenius EUR 9.55B 1.24B Jun/2026
Fresenius Medical Care EUR 5.74B 895.27M Mar/2026
Globus Medical USD 398K 38K Mar/2026
Haemonetics USD 1.17B 50.36M Jun/2026
ICU Medical USD 1.21B 49.38M Jun/2026
Intuitive Surgical USD 0 0 Mar/2025
Medtronic USD 27.88B 255M Dec/2025
Merit Medical Systems USD 736.26M 1.1M Jun/2026
Neogen USD 793.7M 400K Mar/2026
OraSure Technologies USD 100K 17K Dec/2025
Plus Therapeutics USD 3.79M 322K Dec/2022
Quidel USD 2.54B 2.54B Jun/2026
ResMed USD 399.42M 4.75M Jun/2026
STAAR Surgical USD 42K 42K Dec/2023
Steris USD 1.65B 162.6M Jun/2026
Stryker USD 14.19B 32M Jun/2026
Teleflex USD 2.72B 206.24M Jun/2026
Terumo JPY 209.52B 109.61B Jun/2026
Thermo Fisher Scientific USD 39.18B 890M Jun/2026
US Physical Therapy USD 215.46M 21.42M Jun/2026
Zimmer Biomet Holdings USD 6.28B 17.6M Jun/2026